Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Venous Thrombosis 2Venous Thromboembolism 2Neoplasms 2Pulmonary Embolism 1Hemorrhage 1

Interventions

Dalteparin 10apixaban 5Tinzaparin 4Enoxaparin 4Heparin, Low-Molecular-Weight 3edoxaban 2bemiparin 2abelacimab 2Warfarin 2MAA868 2Fondaparinux 2Dabigatran 2reviparin 1isoquercitrin 1certoparin 1calcium heparin 1acarboxyprothrombin 1Rosuvastatin Calcium 1Rivaroxaban 1Phenprocoumon 1Nadroparin 1Heparin 1Educational Status 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Venous Thrombosis × bemiparin × Classical hematology × Clear all
NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00219973 2010-04-28

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

Rovi Pharmaceuticals Laboratories

Phase 3 Completed
526 enrolled
Classical hematology

Hemorrhage, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡